These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8520756)

  • 1. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.
    Seersholm N; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1922-5. PubMed ID: 8520756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.
    Am J Respir Crit Care Med; 1998 Jul; 158(1):49-59. PubMed ID: 9655706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Eriksson S
    Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency.
    Seersholm N; Kok-Jensen A
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):369-73. PubMed ID: 7842193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.
    Eriksson S; Wu MC
    Eur Respir J Suppl; 1990 Mar; 9():39s-43s. PubMed ID: 2340050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency.
    Evald T; Dirksen A; Keittelmann S; Viskum K; Kok-Jensen A
    Lung; 1990; 168 Suppl():579-85. PubMed ID: 2117166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
    Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 10. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
    Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N
    Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.
    Seersholm N; Kok-Jensen A
    Thorax; 1998 Apr; 53(4):265-8. PubMed ID: 9741368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences.
    Xu X; Weiss ST; Rijcken B; Schouten JP
    Eur Respir J; 1994 Jun; 7(6):1056-61. PubMed ID: 7925873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
    Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ.
    Wu MC; Eriksson S
    J Clin Epidemiol; 1988; 41(12):1157-65. PubMed ID: 3264848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
    Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
    Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in FEV1 in patients with PiZ alpha-1-antitrypsin deficiency: the Australian experience.
    Burdon JG; Brenton S; Hocking V; Knight KR; Ayad M; Cook L; Janus ED
    Respirology; 2002 Mar; 7(1):51-5. PubMed ID: 11896901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking, lung function, and alpha 1-antitrypsin deficiency.
    Janus ED; Phillips NT; Carrell RW
    Lancet; 1985 Jan; 1(8421):152-4. PubMed ID: 2857224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
    Eriksson S; Lindell SE; Wiberg R
    Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.